The researchers noted these changes could potentially increase the risk of cardiovascular events
Understanding what semaglutide should look like and recognizing warning signs helps protect you from potential complications including reduced efficacy, unpredictable blood glucose control, or injection site infections
Retrieved from Kaur, N., Chugh, V., & Gupta, A
A synopsis of the evidence for the science and clinical management of cardiovascular-kidney-metabolic (CKM) syndrome: a scientific statement from the American Heart Association
Feel free to watch, comment, say hi, and ask any questionsId love to hear from you there
Genetic Factors in Protein Metabolism and GLP-1 Response Recent genetic research has identified specific pathways influencing how your body processes nutrients and responds to GLP-1 medications